APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icosapent Ethyl Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026

29 December 2025208 pages

Choose your research edition.

Industry ResearchIcosapent Ethyl Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Icosapent Ethyl Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Icosapent Ethyl Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Icosapent Ethyl Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Icosapent Ethyl Drugs market include Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma, Teva and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Icosapent Ethyl Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Icosapent Ethyl Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Icosapent Ethyl Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Icosapent Ethyl Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Icosapent Ethyl Drugs Segment by Company

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Teva

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Icosapent Ethyl Drugs Segment by Type

Single Drug

Combination Drug

Icosapent Ethyl Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Icosapent Ethyl Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Icosapent Ethyl Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Icosapent Ethyl Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Icosapent Ethyl Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Icosapent Ethyl Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icosapent Ethyl Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icosapent Ethyl Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icosapent Ethyl Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Icosapent Ethyl Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Icosapent Ethyl Drugs industry.

Chapter 3: Detailed analysis of Icosapent Ethyl Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Icosapent Ethyl Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Icosapent Ethyl Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Icosapent Ethyl Drugs Industry Trends Table 2. Icosapent Ethyl Drugs Industry Drivers Table 3. Icosapent Ethyl Drugs Industry Opportunities and Challenges Table 4. Icosapent Ethyl Drugs Industry Restraints Table 5. Global Icosapent Ethyl Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Icosapent Ethyl Drugs Revenue Share by Company (2021-2026) Table 7. Global Icosapent Ethyl Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Icosapent Ethyl Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Icosapent Ethyl Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Icosapent Ethyl Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Icosapent Ethyl Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Icosapent Ethyl Drugs Company, Product Type & Application Table 13. Global Icosapent Ethyl Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Icosapent Ethyl Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Drug Table 18. Significant Companies of Combination Drug Table 19. Global Icosapent Ethyl Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Icosapent Ethyl Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Icosapent Ethyl Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Icosapent Ethyl Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Icosapent Ethyl Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Icosapent Ethyl Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Icosapent Ethyl Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Icosapent Ethyl Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Icosapent Ethyl Drugs Sales Value Share by Type (2021-2026) Table 28. Global Icosapent Ethyl Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Online Pharmacy Table 31. Significant Companies of Hospital Pharmacy Table 32. Global Icosapent Ethyl Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Icosapent Ethyl Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Icosapent Ethyl Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Icosapent Ethyl Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Icosapent Ethyl Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Icosapent Ethyl Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Icosapent Ethyl Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Icosapent Ethyl Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Icosapent Ethyl Drugs Sales Value Share by Application (2021-2026) Table 41. Global Icosapent Ethyl Drugs Sales Value Share by Application (2027-2032) Table 42. Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026) Table 45. Global Icosapent Ethyl Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Icosapent Ethyl Drugs Sales Market Share by Region (2027-2032) Table 47. Global Icosapent Ethyl Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Icosapent Ethyl Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Icosapent Ethyl Drugs Sales Value Share by Region (2021-2026) Table 50. Global Icosapent Ethyl Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Icosapent Ethyl Drugs Sales Value Share by Region (2027-2032) Table 52. Global Icosapent Ethyl Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Icosapent Ethyl Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Icosapent Ethyl Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Icosapent Ethyl Drugs Sales Market Share by Country (2021-2026) Table 58. Global Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Icosapent Ethyl Drugs Sales Market Share by Country (2027-2032) Table 60. Global Icosapent Ethyl Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Icosapent Ethyl Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Icosapent Ethyl Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Icosapent Ethyl Drugs Sales Value Market Share by Country (2027-2032) Table 64. Sichuan Gowell Pharmaceutical Company Information Table 65. Sichuan Gowell Pharmaceutical Business Overview Table 66. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 68. Sichuan Gowell Pharmaceutical Recent Development Table 69. Humanwell Puracap Pharmaceuticals Company Information Table 70. Humanwell Puracap Pharmaceuticals Business Overview Table 71. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 73. Humanwell Puracap Pharmaceuticals Recent Development Table 74. Qilu Pharmaceutical Company Information Table 75. Qilu Pharmaceutical Business Overview Table 76. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 78. Qilu Pharmaceutical Recent Development Table 79. Jiangsu Wangao Pharmaceutical Company Information Table 80. Jiangsu Wangao Pharmaceutical Business Overview Table 81. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 83. Jiangsu Wangao Pharmaceutical Recent Development Table 84. Chengdu Suncadia Medicine Company Information Table 85. Chengdu Suncadia Medicine Business Overview Table 86. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio Table 88. Chengdu Suncadia Medicine Recent Development Table 89. Zydus Company Information Table 90. Zydus Business Overview Table 91. Zydus Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zydus Icosapent Ethyl Drugs Product Portfolio Table 93. Zydus Recent Development Table 94. Woodward Pharma Company Information Table 95. Woodward Pharma Business Overview Table 96. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Woodward Pharma Icosapent Ethyl Drugs Product Portfolio Table 98. Woodward Pharma Recent Development Table 99. Teva Company Information Table 100. Teva Business Overview Table 101. Teva Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Teva Icosapent Ethyl Drugs Product Portfolio Table 103. Teva Recent Development Table 104. Sun Pharma Company Information Table 105. Sun Pharma Business Overview Table 106. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sun Pharma Icosapent Ethyl Drugs Product Portfolio Table 108. Sun Pharma Recent Development Table 109. Strides Pharma Company Information Table 110. Strides Pharma Business Overview Table 111. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Strides Pharma Icosapent Ethyl Drugs Product Portfolio Table 113. Strides Pharma Recent Development Table 114. PuraCap Pharmaceuticals Company Information Table 115. PuraCap Pharmaceuticals Business Overview Table 116. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 118. PuraCap Pharmaceuticals Recent Development Table 119. Mankind Pharma Company Information Table 120. Mankind Pharma Business Overview Table 121. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Mankind Pharma Icosapent Ethyl Drugs Product Portfolio Table 123. Mankind Pharma Recent Development Table 124. Hikma Company Information Table 125. Hikma Business Overview Table 126. Hikma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Hikma Icosapent Ethyl Drugs Product Portfolio Table 128. Hikma Recent Development Table 129. GLW Pharma Company Information Table 130. GLW Pharma Business Overview Table 131. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. GLW Pharma Icosapent Ethyl Drugs Product Portfolio Table 133. GLW Pharma Recent Development Table 134. Dr. Reddy's Laboratories Company Information Table 135. Dr. Reddy's Laboratories Business Overview Table 136. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio Table 138. Dr. Reddy's Laboratories Recent Development Table 139. Ascent Pharmaceuticals Company Information Table 140. Ascent Pharmaceuticals Business Overview Table 141. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 143. Ascent Pharmaceuticals Recent Development Table 144. Apotex Company Information Table 145. Apotex Business Overview Table 146. Apotex Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Apotex Icosapent Ethyl Drugs Product Portfolio Table 148. Apotex Recent Development Table 149. Amneal Pharmaceuticals Company Information Table 150. Amneal Pharmaceuticals Business Overview Table 151. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 153. Amneal Pharmaceuticals Recent Development Table 154. Amarin Pharmaceuticals Company Information Table 155. Amarin Pharmaceuticals Business Overview Table 156. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 158. Amarin Pharmaceuticals Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Icosapent Ethyl Drugs Distributors List Table 162. Icosapent Ethyl Drugs Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Icosapent Ethyl Drugs Product Image Figure 2. Global Icosapent Ethyl Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Icosapent Ethyl Drugs Sales (2021-2032) & (K Units) Figure 5. Global Icosapent Ethyl Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Icosapent Ethyl Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Drug Image Figure 10. Combination Drug Image Figure 11. Global Icosapent Ethyl Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Icosapent Ethyl Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Icosapent Ethyl Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Icosapent Ethyl Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Icosapent Ethyl Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Icosapent Ethyl Drugs Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Hospital Pharmacy Image Figure 20. Global Icosapent Ethyl Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Icosapent Ethyl Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Icosapent Ethyl Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Icosapent Ethyl Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Icosapent Ethyl Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Icosapent Ethyl Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Icosapent Ethyl Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Icosapent Ethyl Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Icosapent Ethyl Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Icosapent Ethyl Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Icosapent Ethyl Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Icosapent Ethyl Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Icosapent Ethyl Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Icosapent Ethyl Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Icosapent Ethyl Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Icosapent Ethyl Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Icosapent Ethyl Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Drug
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Teva
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Icosapent Ethyl Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Icosapent Ethyl Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Icosapent Ethyl Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Icosapent Ethyl Drugs Market Dynamics
  1. 2.1 Icosapent Ethyl Drugs Industry Trends
  2. 2.2 Icosapent Ethyl Drugs Industry Drivers
  3. 2.3 Icosapent Ethyl Drugs Industry Opportunities and Challenges
  4. 2.4 Icosapent Ethyl Drugs Industry Restraints
3 Icosapent Ethyl Drugs Market by Company
  1. 3.1 Global Icosapent Ethyl Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Icosapent Ethyl Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Icosapent Ethyl Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Icosapent Ethyl Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Icosapent Ethyl Drugs Company Ranking (2024-2026)
  6. 3.6 Global Icosapent Ethyl Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Icosapent Ethyl Drugs Company Product Type and Application
  8. 3.8 Global Icosapent Ethyl Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Icosapent Ethyl Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Icosapent Ethyl Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Icosapent Ethyl Drugs Market by Type
  1. 4.1 Icosapent Ethyl Drugs Type Introduction
  2. 4.1.1 Single Drug
  3. 4.1.2 Combination Drug
  4. 4.2 Global Icosapent Ethyl Drugs Sales Volume by Type
  5. 4.2.1 Global Icosapent Ethyl Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Icosapent Ethyl Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Icosapent Ethyl Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Icosapent Ethyl Drugs Sales Value by Type
  9. 4.3.1 Global Icosapent Ethyl Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Icosapent Ethyl Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Icosapent Ethyl Drugs Sales Value Share by Type (2021-2032)
5 Icosapent Ethyl Drugs Market by Application
  1. 5.1 Icosapent Ethyl Drugs Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Icosapent Ethyl Drugs Sales Volume by Application
  6. 5.2.1 Global Icosapent Ethyl Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icosapent Ethyl Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Icosapent Ethyl Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Icosapent Ethyl Drugs Sales Value by Application
  10. 5.3.1 Global Icosapent Ethyl Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Icosapent Ethyl Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Icosapent Ethyl Drugs Sales Value Share by Application (2021-2032)
6 Icosapent Ethyl Drugs Regional Sales and Value Analysis
  1. 6.1 Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Icosapent Ethyl Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Icosapent Ethyl Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Icosapent Ethyl Drugs Sales by Region (2027-2032)
  5. 6.3 Global Icosapent Ethyl Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Icosapent Ethyl Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Icosapent Ethyl Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Icosapent Ethyl Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Icosapent Ethyl Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Icosapent Ethyl Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Icosapent Ethyl Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Icosapent Ethyl Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Icosapent Ethyl Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Icosapent Ethyl Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Icosapent Ethyl Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Icosapent Ethyl Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Icosapent Ethyl Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Icosapent Ethyl Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Icosapent Ethyl Drugs Sales Value Share by Country, 2025 VS 2032
7 Icosapent Ethyl Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Icosapent Ethyl Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Icosapent Ethyl Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Icosapent Ethyl Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Icosapent Ethyl Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Icosapent Ethyl Drugs Sales by Country (2027-2032)
  6. 7.4 Global Icosapent Ethyl Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Icosapent Ethyl Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Icosapent Ethyl Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Icosapent Ethyl Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Icosapent Ethyl Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Icosapent Ethyl Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sichuan Gowell Pharmaceutical
  2. 8.1.1 Sichuan Gowell Pharmaceutical Company Information
  3. 8.1.2 Sichuan Gowell Pharmaceutical Business Overview
  4. 8.1.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  6. 8.1.5 Sichuan Gowell Pharmaceutical Recent Developments
  7. 8.2 Humanwell Puracap Pharmaceuticals
  8. 8.2.1 Humanwell Puracap Pharmaceuticals Company Information
  9. 8.2.2 Humanwell Puracap Pharmaceuticals Business Overview
  10. 8.2.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  12. 8.2.5 Humanwell Puracap Pharmaceuticals Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Jiangsu Wangao Pharmaceutical
  20. 8.4.1 Jiangsu Wangao Pharmaceutical Company Information
  21. 8.4.2 Jiangsu Wangao Pharmaceutical Business Overview
  22. 8.4.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  24. 8.4.5 Jiangsu Wangao Pharmaceutical Recent Developments
  25. 8.5 Chengdu Suncadia Medicine
  26. 8.5.1 Chengdu Suncadia Medicine Company Information
  27. 8.5.2 Chengdu Suncadia Medicine Business Overview
  28. 8.5.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
  30. 8.5.5 Chengdu Suncadia Medicine Recent Developments
  31. 8.6 Zydus
  32. 8.6.1 Zydus Company Information
  33. 8.6.2 Zydus Business Overview
  34. 8.6.3 Zydus Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Icosapent Ethyl Drugs Product Portfolio
  36. 8.6.5 Zydus Recent Developments
  37. 8.7 Woodward Pharma
  38. 8.7.1 Woodward Pharma Company Information
  39. 8.7.2 Woodward Pharma Business Overview
  40. 8.7.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
  42. 8.7.5 Woodward Pharma Recent Developments
  43. 8.8 Teva
  44. 8.8.1 Teva Company Information
  45. 8.8.2 Teva Business Overview
  46. 8.8.3 Teva Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Icosapent Ethyl Drugs Product Portfolio
  48. 8.8.5 Teva Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Strides Pharma
  56. 8.10.1 Strides Pharma Company Information
  57. 8.10.2 Strides Pharma Business Overview
  58. 8.10.3 Strides Pharma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
  60. 8.10.5 Strides Pharma Recent Developments
  61. 8.11 PuraCap Pharmaceuticals
  62. 8.11.1 PuraCap Pharmaceuticals Company Information
  63. 8.11.2 PuraCap Pharmaceuticals Business Overview
  64. 8.11.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  66. 8.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 8.12 Mankind Pharma
  68. 8.12.1 Mankind Pharma Company Information
  69. 8.12.2 Mankind Pharma Business Overview
  70. 8.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
  72. 8.12.5 Mankind Pharma Recent Developments
  73. 8.13 Hikma
  74. 8.13.1 Hikma Company Information
  75. 8.13.2 Hikma Business Overview
  76. 8.13.3 Hikma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Icosapent Ethyl Drugs Product Portfolio
  78. 8.13.5 Hikma Recent Developments
  79. 8.14 GLW Pharma
  80. 8.14.1 GLW Pharma Company Information
  81. 8.14.2 GLW Pharma Business Overview
  82. 8.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
  84. 8.14.5 GLW Pharma Recent Developments
  85. 8.15 Dr. Reddy's Laboratories
  86. 8.15.1 Dr. Reddy's Laboratories Company Information
  87. 8.15.2 Dr. Reddy's Laboratories Business Overview
  88. 8.15.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
  90. 8.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 8.16 Ascent Pharmaceuticals
  92. 8.16.1 Ascent Pharmaceuticals Company Information
  93. 8.16.2 Ascent Pharmaceuticals Business Overview
  94. 8.16.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  96. 8.16.5 Ascent Pharmaceuticals Recent Developments
  97. 8.17 Apotex
  98. 8.17.1 Apotex Company Information
  99. 8.17.2 Apotex Business Overview
  100. 8.17.3 Apotex Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Icosapent Ethyl Drugs Product Portfolio
  102. 8.17.5 Apotex Recent Developments
  103. 8.18 Amneal Pharmaceuticals
  104. 8.18.1 Amneal Pharmaceuticals Company Information
  105. 8.18.2 Amneal Pharmaceuticals Business Overview
  106. 8.18.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  108. 8.18.5 Amneal Pharmaceuticals Recent Developments
  109. 8.19 Amarin Pharmaceuticals
  110. 8.19.1 Amarin Pharmaceuticals Company Information
  111. 8.19.2 Amarin Pharmaceuticals Business Overview
  112. 8.19.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  114. 8.19.5 Amarin Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Icosapent Ethyl Drugs Value Chain Analysis
  2. 9.1.1 Icosapent Ethyl Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Icosapent Ethyl Drugs Sales Mode & Process
  6. 9.2 Icosapent Ethyl Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Icosapent Ethyl Drugs Distributors
  9. 9.2.3 Icosapent Ethyl Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst